Work for Merus?

Claim Your Profile

Merus Logo Image

Merus

Merus Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

2018 Annual Report

Merus

Annual
Report

Merus has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

Archived Annual Reports

  • Merus
  • Merus

About Merus

51-200 Employees
Based in Utrecht, Netherlands

Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Their most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.

Ticker:
MRUS
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol